TCIM
OXFD

TIAA CREF Investment Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

TIAA CREF Investment Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$3.42M Buy
198,804
+57,783
+41% +$914K ﹤0.01% 1684
2018
Q4 		$1.8M Buy
141,021
+18,430
+15% +$280K ﹤0.01% 2018
2018
Q3 		$1.99M Buy
122,591
+17,244
+16% +$247K ﹤0.01% 2122
2018
Q2 		$1.36M Buy
105,347
+19,055
+22% +$257K ﹤0.01% 2367
2018
Q1 		$1.07M Buy
86,292
+870
+1% +$10.6K ﹤0.01% 2404
2017
Q4 		$1.19M Buy
85,422
+568
+0.7% +$8.32K ﹤0.01% 2382
2017
Q3 		$1.43M Buy
84,854
+8,760
+12% +$143K ﹤0.01% 2342
2017
Q2 		$1.28M Buy
76,094
+4,840
+7% +$72.3K ﹤0.01% 2425
2017
Q1 		$1.1M Sell
71,254
-1,301
-2% -$18.6K ﹤0.01% 2462
2016
Q4 		$1.08M Buy
72,555
+6,016
+9% +$84.5K ﹤0.01% 2490
2016
Q3 		$836 Sell
66,539
-4,370
-6% -$43.9K ﹤0.01% 2628
2016
Q2 		$638K Buy
70,909
+6,456
+10% +$63.2K ﹤0.01% 2763
2016
Q1 		$639K Hold
64,453
– – ﹤0.01% 2697
2015
Q4 		$741K Hold
64,453
– – ﹤0.01% 2747
2015
Q3 		$870K Hold
64,453
– – ﹤0.01% 2646
2015
Q2 		$893K Buy
64,453
+13,526
+27% +$183K ﹤0.01% 2745
2015
Q1 		$717K Hold
50,927
– – ﹤0.01% 2800
2014
Q4 		$694K Buy
50,927
+1,250
+3% +$17.1K ﹤0.01% 2848
2014
Q3 		$759K Hold
49,677
– – ﹤0.01% 2792
2014
Q2 		$836K Buy
49,677
+33,697
+211% +$607K ﹤0.01% 2825
2014
Q1 		$321K Hold
15,980
– – ﹤0.01% 3038
2013
Q4 		$310K Buy
+15,980
New +$283K ﹤0.01% 3054

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

TIAA CREF Investment Management's OXFD Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Oxford Immunotec Global PLC Ordinary Shares (OXFD) stake by 41% in Q1 2019, buying an estimated $914K and bringing the position to 198,804 shares worth $3.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1684.

TIAA CREF Investment Management first reported a position in OXFD in Q4 2013 and has held it in 22 quarters since. 92 funds tracked by Wall St. Rank hold OXFD as of Q1 2019.

  • TIAA CREF Investment Management held 198,804 shares of Oxford Immunotec Global PLC Ordinary Shares worth $3.42M as of Q1 2019.
  • TIAA CREF Investment Management bought 57,783 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2019, an estimated $914K.
  • Oxford Immunotec Global PLC Ordinary Shares made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #1684 holding.
  • TIAA CREF Investment Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and has held it in 22 quarters since.
  • 92 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.